Dina Iwai, MD specializes in pediatric critical care medicine with special interest in acute respiratory distress syndrome (ARDS). Dr. Iwai is board certified in pediatrics and board eligible in pediatric critical care and is a Clinical Instructor at UC Irvine. Dr. Iwai completed her internship, residency and fellowship trainnig at Los Angeles County/USC Medical Center. She received her medical degree from the University of California, Los Angeles School of Medicine.
Medical Director of the Pediatric Intensive Care Unit at CHOC at Mission in Mission Viejo, Gary Goodman, M.D. specializes in pediatric critical care with expertise in the treatment of shock, RSV and traumatic brain injury. He is board certified in both pediatrics and pediatric critical care medicine. Dr. Goodman served his fellowship at Children’s Hospital of Orange County. He received his medical training at the University of California, Irvine and completed both his residency and internship at UC Davis Medical Center. Dr. Goodman was voted as one of Orange County’s Top Doctors in 2009.
Michele Domico, M.D. is a pediatric critical care attending physician at CHOC Hospital of Orange County, California and a Clinical Instructor at UC Irvine with an expertise in pediatric cardiac intensive care and extracorporeal membrane oxygenation (ECMO).
Dr. Domico is board certified in both pediatrics and pediatric critical care medicine. Dr. Domico has served as Senior Fellow in pediatric cardiac intensive care/ECMO at the Great Ormond Street Hospital for Children in London, England. She completed her pediatric critical care fellowship at Harbor-UCLA Medical Center and CHOC Children’s Hospital of Orange County, California. She also had additional fellowship training in pediatric cardiology at the University of Florida Health Science Center in Gainesville, Florida. Dr. Domico attended medical school and completed her internship and residency at University of Texas Health Science Center in San Antonio, Texas.
Dr. Domico is a published clinical researcher with a focus on cardiac intensive care, septic shock and ECMO for cardiac or respiratory failure.
Nancy Chung, M.D. is board certified in Pediatrics and trained in Pediatric Critical Care. Dr. Chung attended medical school at University of Alberta, Canada. She interned at Pasqua Hospital, Regina through the University of Saskatchewan, Canada. She completed her pediatric training, including chief residency at University of Alberta, now known as Stollery Children’s Hospital.
Dr. Chung immigrated to the USA and completed a pediatric Critical Care Fellowship at the combined program at UCSF/Children’s Hospital, Oakland. Upon completing her fellowship, she took on the role of full-time motherhood and has now returned to the practice of medicine.
Dr. Chung is affiliated with the AAP, SCCM, Royal College of Physicians & Surgeons of Canada and the Canadian Pediatric Society. Her philosophy of care is to provide exemplary care through collaboration within a multidisciplinary team.
James Cappon, M.D. provides the full range of tertiary-level critical care procedures, with expertise in mechanical ventilation and management of respiratory failure. He is board certified in both pediatrics and pediatric critical care medicine. Dr. Cappon served his fellowship at Harbor-UCLA/CHOC /Martin Luther King hospitals. Both his residency and internship were completed at Harbor/UCLA Medical Center in Torrance. Dr. Cappon is a graduate of the University of New Mexico School of Medicine in Albuquerque. Dr. Cappon is fluent in Spanish. Dr. Cappon also serves as the CHOC Director of Patient Safety.
[youtubegallery]
Dr. Jim Cappon tells us about his motivation in making CHOC better place|http://www.youtube.com/watch?v=5C3DRTVyn6A
[/youtubegallery]
Dr. Huang received his MD degree from the Fujian Medical University, his PhD in Biomedical Sciences from Mt. Sinai School of Medicine. He completed his internship and residency in pediatrics at Georgetown University Medical Center, and his clinical genetics and clinical molecular genetics fellowship at Harvard Medical School.
Dr. Huang is Board Certified in general pediatrics by the American Board of Pediatrics, in clinical genetics and clinical molecular genetics by the American Board of Medical Genetics.
He is affiliated with UCI and received the UCI Dean’s Physician-Scientist Award. He is also fluent in Chinese (Mandarin).
Jose Camacho, M.D. is CHOC Specialist in Chemical and Biochemical Genetics, board certified by the American Academy of Pediatrics in pediatrics and medical biochemical genetics. Dr. Camacho received his medical degree from the University Central del Caribe, School of Medicine in Puerto Rico. He completed his internship and residency training at the University of Missouri, Columbia Medical Center in Columbia, Missouri. Dr. Camacho completed fellowship training in human genetics at the Johns Hopkins University Hospital.
He is a member of Alpha Omega Alpha. Dr. Camacho received the American Society of Human Genetics Research (Post-Doc) Award and the Robert Wood Johnson Foundation Faculty Development Award. Dr. Camacho is fluent in Spanish. His special interests include research in Urea Cycle Disorders and Mitochondrial Carrier Proteins. His philosophy is that patient care always comes first.
Dr. Maureen Bocian is a medical geneticist specializing in the diagnosis and management of genetic syndromes, birth defects, and genetically-based intellectual disabilities. She has particular interests in chromosomal abnormalities, neurofibromatosis, craniofacial disorders, prenatal genetics, and skeletal dysplasias. Her research interests include new syndrome identification; variability, heterogeneity, and natural history of genetic disorders; and the genetic basis of autism.
Dr. Bocian received her undergraduate degree from the University of California, Berkeley and both a Master’s degree in microbiology and immunology and an MD degree from the University of Illinois at Chicago. She completed her internship and residency in Pediatrics at Children’s Memorial Hospital, Northwestern University, Chicago, Illinois and her fellowship training in Medical Genetics at Harbor-UCLA Medical Center. She is a Professor of Pediatrics in the UC Irvine School of Medicine and has been a full-time faculty member since 1979. She is Director of the UC Irvine Medical Genetics Residency Program.
Dr. Bocian is Board Certified in Clinical Genetics, Clinical Cytogenetics, and Pediatrics and is a Fellow of the American College of Medical Genetics and of the American Academy of Pediatrics. She is also a member of the American Society of Human Genetics and the Western Society for Pediatric Research.
Dr. Bocian has been listed five times among the “Best Doctors in America” and has received three UC Irvine School of Medicine Excellence in Teaching awards. She is also fluent in Spanish.
Christina Schwindt, M.D. is board certified in both pediatrics and allergy, asthma and immunology. Her expertise is in the dignosis and treatment of asthma, allergies and primary immunodeficiencies. Dr. Schwindt’s research is focused on understanding the environmental factors that may influence the increase in asthma seen worldwide. She has developed an asthma clinic in St. Vincent and the Grenadines in the West Indies and has a particular interest in providing care for underserved populations. Dr. Schwindt received her medical training at the St. Louis University School of Medicine and received her internship, residency and fellowship training at the St. Louis University Group of Hospitals.
Article Link: Dr. Christina Schwindt leads UC Irvine effort to treat children’s food allergies.
1201 West La Veta, CHOC West 2nd Floor, Orange CA 92868
27700 Medical Center Road, Mission Viejo CA 92868
1201 West La Veta, Orange CA 92868
505 S. Main St., Suite 350, Orange, CA 92868
26691 Plaza, Suite 130, Mission Viejo, CA 92691
1201 West La Veta, CHOC West 1st Floor, Orange, CA 92868
2500 Red Hill Ave, Suite 100, Santa Ana, CA 92705
Phone: (949) 267-0400
Fax: (949) 221-0004
1 Medical Plaza Drive, Irvine CA 92697
393 South Tustin Street, Orange CA 92866
520 Superior Ave., Suite 160, Newport Beach, CA 92663
1 Hoag Drive, Newport Beach CA 92663
CHOC Specialty Center
500 Superior Ave., Suite 140
Newport Beach, CA 92660
3865 Jackson Street, Riverside CA 92503
12291 Washington Boulevard, Whittier, CA 90606
1798 N. Garey Avenue, Pomona CA 91767
1310 West Stewart Ave., Suite 212, Orange CA 92868
1100 West Stewart Drive, Orange, CA 92868
4050 Barranca Pkwy., Suite 200, Irvine CA 92604
101 East Valenica Mesa Drive, Fullerton, CA 92835
2650 Elm Ave., Elm Avenue Medical Plaza – Suite 301, Long Beach, CA 90806
101 The City Drive South, Orange CA 92868
26732 Crown Valley Parkway, Suite 261, Mission Viejo, CA 92691
1001 Tustin Ave., Santa Ana CA 92705
Mark Ellis, M.D., is the Chief of the CHOC Specialists Allergy & Immunology Division, Director of Allergy, Asthma & Immunology Program at CHOC, and a member of the St. Joseph Hospital Nasal and Sinus Center and a Associate Clinical Professor at UC Irvine. He is board certified in pediatrics and in allergy, asthma and immunology.
Dr. Ellis served his fellowship at UCI Medical Center in Orange. He completed his internship and residency through the University of Arizona Health Sciences Center in Phoenix. Dr. Ellis graduated from the Tulane University School of Medicine in New Orleans.
Dr. Ellis specializes in the treatment and management of allergies and asthma, including specialized care for sinusitis. Dr. Ellis is an award-winning principal investigator for many clinical trials and research studies for both adults and children, concerning new treatments for asthma and allergies. Dr. Ellis was voted as one of Orange County’s Top Doctors for 2009 & 2010.
Ellis M. Successful Treatment of Chronic Urticaria Using Leukotriene Antagonists. J Allergy Clin Immunol 1998; 102:876-77.
Nayak A, Ellis M, Gross G, Mendelson L, Schenkel E, Lanier B, Simpson B, Mullin M, Smith J. The Effects of Triamcinolone Acetonide Aqueous Nasal Spray on Adrenocortical Function in Children With Allergic Rhinitis. J Allergy Clin Immunol 1998; 101:157-62.
Telez-Diaz G, Ellis M, Morales-Russo F, Heiner D. Prevalence of Avocado Allergy Among Atopic Patients. Allergy Proceedings, September-October 1995:16:5:241-243.
Scott C. The Effect of Nedrocromil Sodium on Childhood Asthma During The Viral Season. American Journal of Respiratory and Critical Care Medicine, 1995:152:1879-1886. Konig P, Eigen H, Ellis M, Ellis E, Blake K, Geller D, Shapiro G, Welch M, Chiu J, Nelson B, Sokol W, Ellis M, Galant S, and Novey H. Extended Evaluation of Diagnostic Skin Testing Practices in Orange County, California.Allergy Proceedings, July-August 1993:14:4:283-286.
Ellis M, Short J, and Heiner D. Anaphylaxis Following Ingestion of a Recently Introduced Hydroyzed Whey Protein Formula. Journal of Pediatrics, 1991:118:74-77.
Ellis M and Gallup J. Aeroallergans in Southern California. Chapter in Immunology and Allergy Clinics of North America. William Solomon Editor. WB Saunders, 1989:9:365-380.
Ellis M, Haydik L, Gillman S, Cummins L and Cairo M. Immediate Adverse Reactions to Acetaminophen in Children: Evaluation of Histamine Release and Spirometry. Journal of Pediatrics, 1989: 114:654-656.
Shimizu M, Vayuvegula B, Ellis M, Gluck L, and Gupta S. Regulation of Immune Functions by Human Surfactant. Annals of Allergy, 1988, 61:459-462.
Ellis M, Gupta S, Galant S, Hakim S, Vandeven C, Toy C, and Cairo M. Impaired Neutrophil Function in Patients with AIDS or AIDS-Related Complex: A Comprehensive Evaluation. Journal of Infectious Diseases, 1988. 158: 1268-1276.
Gupta S, Ellis M, Cesario T, Ruhling M, and Vayuvegula B. Disseminated Cryptococcal Infection in a Patient with Hypogamma-globulinemia and Normal T Cell Functions. American Journal of Medicine, 1987: 82:129-131
Abstracts
Ellis M, Cruz-Rivera M, Walten-Bowen K, Smith JA. Improved Asthma Control with Once-Daily Budesonide Inhalation Suspension (BIS; Pulmicort Respules™) in Children 4 Years of Age. J Allergy Clin Immunol, 1999: Vol 103 No 1, Part 2 PS130.
Ellis M, Jacobson R, and Hollman D. Allergy to Solonopis Aurea, An Uncommon Native Fire Ant. JACI, 1992;89:293. Presented to the Academy of Allergy and Immunology, Mar 1992, Orlando, FL.
Konig P, Eigen H, Ellis M, Ellis E, Geller D, Scott C, Shapiro G, and Welch M. Nedocromil Sodium Prevents Increased Asthma Symptoms In Children Whose Asthma Is Exacerbated During the Viral Season. JACI, 1992;89:235. Presented to the Academy of Allergy and Immunology, Mar, 1992, Orlando, FL
Hoffman D, and Ellis M. Allergy to Chicken Meat JACI, 1991;87:192. Presented to the American Academy of Allergy and Immunology, Mar. 1991, San Francisco, CA. Haydik I, Ellis M, Novey H, Cummins L, Gillman S, Houshiar A, and Wilson A. Basophil Histamine (BHR) Correlates Well with Alternaria Bronchial Challenge in Asthmatics, JACI, 1989;83:185. Presented to the American Academy of Allergy and Immunology, Feb. 1989, San Antonio, TX.
Ellis M, Novey H, Gillman S, Cummins L, and Wilson A. Evaluation of Alternaria Sensitive Asthmatics, JACI, 1988;80. Presented to the American College of Allergy and Immunology, Nov. 1988, Los Angeles, CA.
Ellis M, Haydik I, Gillman S, Cummins L, and Cairo M. Immediate Adverse Reaction to Acetaminophen. Oral Presentation, American Academy of Allergy and Immunology, March 1988, Anaheim, CA.
Galant S, Posner L, Lee N, Hicks D, Wilderson B, and Ellis M. Immediate Hypersensitivity to Semisynthetic Penicillins in Cystic Fibrosis; Journal of Allergy and Clinical Immunology, 1987; 77:199. Presented in Washington DC, March 1987.
Ellis M, Vayuvegula B, and Gupta S. Regulation of Macrophage Functions By Surfactant: Annal of Allergy, 1986; Vol. 57. Presented in Las Vegas, January 1987.
Ellis M, Dumars K, Gillman S, VandeVen C, Heiner D and Cairo M. Familial IgG4 Sub Class Deficiency With Normal IgA Associated and Recurrent Infection with Decreased Neutrophil Chemotaxis and Bacterial Killing; Society of Pediatric Research, 1987.
Cairo M, Vandeven C, Gupta S, and Ellis M. Abnormal Polymorphonuclear Function Including Bacterial Killing, C. Albicans, Phagocytosis, Chemotaxis and PMN Mo-1 Expression in ARC and AIDS: International Society of Preventative Oncology. Presented in Nice, France, April 1987.
Ellis M, Gupta S, Vandeven C, Wong C, Litke T, and Cairo M. Heat Liable Serum Inhibitor of Polymorphonuclear Leukocyte (PMN) Chemotaxis and Bacterial Killing in Pre-Acquired Immunodeficiency Syndrome (pre-AIDS) and AIDS; Journal Allergy and Clinical Immunology, 1986; 77:127. Presented in New Orleans, March 1986.
Chen W, Ellis M, Vayuvegula B, Purtillo D, Galant S, Cair M, and Gupta S. In Vitro Inhibition of Immunoglobulin Secretion by Adherent Monocytes in a Patient with X-Linked Lymphoproliferative (XLP) Syndrome and Hypogammaglobulinemia: American Federation of Clinical Research, 1986.
Joshua Gibbs, D.O, PSF Allergist and Clinical Immunologist, treats patients of all ages with asthma, allergic or immunologic conditions. He is board certified in internal medicine and in allergy/clinical immunology.
Dr. Gibbs served as Chief Fellow during his allergy/clinical immunology fellowship at Penn State University in Hershey, PA. He completed an internal medicine residency at Thomas Jefferson University Hospital in Philadelphia. His osteopathic rotating internship was performed at Crozer-Keystone Health System in Delaware County, Pennsylvania. Dr. Gibbs graduated from the Philadelphia College of Osteopathic Medicine in Philadelphia.
His special interests include treating patients with hereditary angioedema, drug allergy, rhinitis, asthma and chronic rhino sinusitis.
Dr. Joshua Gibbs discusses the fact that children’s food allergies are on the rise.
With more than 50 years of experience, Melville Singer, M.D. treats the full spectrum of pediatric cardiology related conditions, with specialized expertise in adults with congenital heart disease.
Dr. Singer is board certified in both pediatrics and pediatric cardiology and is a Associate Clnical Professor at UC Irvine. He served his fellowship and residency at Children’s Hospital in Cincinnati. He received his medical training at Ohio State University, in Cincinnati, and completed his internship at Cincinnati General Hospital.
CHOC Specialists Cardiology practice office moving – Monday, August 1st, 2011
Pierangelo Renella, M.D. received his medical degree from the University of California, Irvine School of Medicine. He did his Pediatric Internship and Residency at Children’s Hospital Los Angeles. Dr. Renella has completed Fellowships in Pediatric Cardiology and Advanced Non-Invasive Cardiovascular Imaging at the University of California Los Angeles and Children’s Hospital Boston.
Dr. Renella is involved in multiple clinical research projects involving cardiac MRI and CT. In addition, he is sub-specialized in fetal cardiology and fetal cardiac imaging. He is currently developing a dedicated congenital cardiac MRI and CT program at CHOC.
Dr. Renella is board certified in pediatrics and pediatric cardiology and speaks fluent Spanish and Italian.
CHOC Specialists Cardiology practice office moving – Monday, August 1st, 2011
1) Investigating the feasibility of 3D echocadiography for right ventricular volumetric and functional assessment in children.
2) Right and left ventricular volumetric and functional assessment by cardiac MRI in severely anemic patients with iron overload.
3) The significance of regional right ventricular function in repaired Tetralogy of Fallot patients as assessed by cardiac MRI.
Pediatric cardiologist Linda Muhonen, M.D. provides care for the full spectrum of related conditions with special emphasis in preventive cardiology. Additionally, she directs the Children’s Cholesterol Clinic located at CHOC and CHOC at Mission in Mission Viejo.
Dr. Muhonen is board certified in pediatric cardiology. She completed her 3rd year of residency and training at the University of Iowa Hospital in Iowa City, Iowa.
Dr. Muhonen completed her 2nd year of residency and training at Loma Linda University Medical Center. Dr. Muhonen received her medical training at Oral Roberts University in Tulsa, Oklahoma.
CHOC Specialists Cardiology practice office moving – Monday, August 1st, 2011
Orange County American Academy of Pediatrics, California Chapter 4
When a life-threatening situation arises, CHOC Specialists Critical Care physicians are available 24-hours-a-day, seven days a week and provide comprehensive services for acutely ill or seriously injured children and adolescents. These board certified or board admissible pediatric subspecialists serve as medical directors for the 24-bed Pediatric Intensive Care Unit (PICU) at CHOC, the eight-bed PICU located within CHOC at Mission, and pediatric units at select Orange County hospitals.
Additionally, CHOC Specialists Critical Care physicians are available for immediate consultation and intervention in the event patients admitted into other areas of the hospital experience unforeseen complications. They provide 24-hour coverage for the emergency departments at both CHOC and CHOC at Mission. If a life-threatening situation arises, they are immediately available.
Regionally Recognized for Expert, Tertiary-Level Critical Care
With more than 30 years of experience, CHOC Specialists Critical Care physicians are regionally recognized for their expertise and treat critically ill patients from throughout Southern California. They treat the full spectrum of pathology and disease, from the very common to the very rare. Patients with a wide range of disorders are hospitalized in the PICU, including those with:
Through participation in multi-center studies of children with life-threatening respiratory failure, CHOC Specialists Critical Care physicians provide the most technically advanced therapies, such as extracorporeal membrane oxygenation (ECMO), high-frequency oscillation and the use of nitric oxide. Under their leadership, CHOC has had a successful ECMO program for more than 25 years.
CHOC Specialists Critical Care physicians also are integral to the CHOC Cancer, Neuroscience, Cardiac and Orthopaedic Institutes. Their services are complemented by the multidisciplinary care provided by other pediatric subspecialty physicians, nurses, respiratory therapists, pharmacists, physical therapists, occupational therapists, speech pathologists, clinical dietitians, child psychologists and social workers at CHOC and CHOC at Mission.
According to Virtual Pediatric Systems, LLC (VPS), a national collaborative of over 200 ICUs, when compared to a cohort of 19 similar PICUs, the CHOC PICU had:
24-Hour Transport Service to CHOC and CHOC at Mission
The availability of 24-hour transport services allows CHOC Specialists Critical Care physicians to bring critical care directly to the patient — and then to bring the patient back safely to either CHOC or CHOC at Mission. The sophisticated and highly specialized CHOC Transport Service is the only one in the region equipped with a pediatric high frequency oscillator and state-of-the-art ventilator.
By ambulance or helicopter, our team is available to transport children from emergency rooms, hospital nurseries, pediatric facilities and physician offices from throughout the Southern California region. Non-emergent (ACLS) transport services are also available and may be arranged by calling the Pediatric Transport Team at either CHOC or CHOC at Mission.
Fellowship Program & Professional Education
In addition to direct patient care responsibilities, CHOC Specialists Critical Care physicians are committed to advances in pediatric medicine through research, teaching and tertiary clinical training. In addition to teaching Residents at CHOC, they also teach fellows. CHOC Specialists Critical Care has trained over 70 critical care fellows in the past 20 years. CHOC Specialists Critical Care physicians are active members in the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network and currently involved in multiple national clinical trials. Several of our physicians hold faculty positions in the Department of Pediatrics at Harbor-UCLA Medical Center. The Pediatric Critical Care Fellowship Program (CHOC/Harbor-UCLA Medical Center) is ACGME-approved and has graduated 25 board admissible pediatric intensivists during the last 10 years.
Additionally, CHOC Specialists Critical Care physicians provide continuing medical education, outreach programs and consulting services to the pediatric community and to the multidisciplinary subspecialty teams at CHOC and CHOC at Mission.
Family Support and Care
CHOC Specialists Critical Care physicians are committed to the health and well-being of the children of Southern California. Medical care is provided with compassion, offering each family the necessary information to understand the child’s condition and anticipated outcome.
Developed by CHOC Specialists, in partnership with community physicians, these guidelines provide you with useful information in working up your patients, and contribute to making the appointment itself most meaningful by having the right clinical information available.
Listed below are the specialties that currently have guidelines. Updates, as well as additional specialties and diagnoses, are added regularly.
Please note: All information is for educational purposes only. For specific medical advice, diagnoses, and treatment, consult your doctor.
Visit CHOC.org/referrals for patient referral information.
Referral Guidelines and Forms are available to assist referring physicians in the evaluation and management of pediatric patients.
Visit the CHOC Docs webpage on CHOC.org for more information, tools and resources for CHOC physicians.
For information about current and future rheumatology research studies at CHOC, please visit:
CHOC Rheumatology Research Clinical Trials
For more information, please contact:
CHOC Children’s Specialists Rheumatology administrative office at 714-509-8617.
For information about current and future pulmonology research studies at CHOC, please visit:
CHOC Pulmonology Research Clinical Trials
For more information, please contact:
CHOC Children’s Specialists Pulmonology administrative office at 714-509-8622.
For information about current and future oncology research studies at CHOC, please visit:
CHOC Oncology Research Clinical Trials
For more information, please contact:
CHOC Children’s Specialists Oncology administrative office at 714-509-4348.
For information about current and future neurology research studies at CHOC, please visit:
CHOC Neurology Research Clinical Trials
For more information, please contact:
CHOC Children’s Specialists Neurology administrative office at 714-509-7601.
For more information, please contact:
CHOC Children’s Specialists Hematology administrative office at 714-509-8324.
For information about current and future infectious disease research studies at CHOC, please visit:
CHOC Infectious Disease Research Clinical Trials
For more information, please contact:
CHOC Children’s Specialists Infectious Disease administrative office at 714-509-8403.
For information about current and future hematology research studies at CHOC, please visit:
CHOC Hematology Research Clinical Trials
For more information, please contact our CHOC Children’s Specialists Hematology administrative office at 714-509-8459.
For more information, please contact our CHOC Children’s Specialists Gastroenterology administrative office at 714-509-4099.
For information about current and future endocrinology research studies at CHOC, please visit:
CHOC Endocrinology Research Clinical Trials
For more information, please contact our administrative office at 714-509-8634.
For information about current and future critical care research studies at CHOC, please visit:
CHOC Critical Care Research Clinical Trials
For more information, please contact our critical care administrative office at (714) 509-8620.
For information about current and future cardiology research studies at CHOC, please visit:
CHOC Cardiology Research Clinical Trials
For more information, please contact our CHOC Specialists Cardiology administrative office at 714-509-3939.
We continue our research efforts in the area of cord blood research, working to make transplants more effective and more available to patients suffering from a variety of cancers and other conditions, including auto-immune disorders. The CHOC Cord Blood Bank is one of only ten NMDP Cord Blood Banks in the country. Through the NMDP Registry, our bank provides cord blood units to transplant patients worldwide.
For more information, please contact Vicki Slone in the Cord Blood Program at CHOC at (714) 509-4154.
For information about current and future allergy and immunology research studies at CHOC, please visit:
CHOC Allergy & Immunology Research Clinical Trials
For more information, please contact our allergy and immunology administrative office at 714-633-6363.
CHOC Specialists Allergy, Asthma and Immunology physicians provide comprehensive treatment based on prevention, intervention, education and self-management. Recognized for excellence by their peers and actively involved in clinical research, they offer the latest treatment options for patients of all ages with allergic or immunologic conditions. CHOC Specialists Allergy and Immunology physicians have special expertise in caring for the medically fragile and those who have not responded to conventional therapy.
Treatment modalities include pharmacotherapy, immunotherapy, dietary control and environmental allergen/irritant avoidance. Inpatient and outpatient services are available for children and adults experiencing conditions related to allergies, asthma and immune deficiencies, including:
Early Intervention and Outpatient Management For Acute Asthma, CHOC Specialists Allergy, Asthma and Immunology physicians are committed to providing preventive care and early intervention for asthmatic patents. Managing severe asthma exacerbations in the office has been effective in reducing the number of emergency room visits, hospitalizations and days missed from school and work.
Cost-Effective Allergy Care Emphasizing Education and Prevention The Allergy evaluation begins with a medical history, diagnostic evaluation and environmental assessment. At the conclusion of the first appointment, each patient receives a detailed treatment plan, plus educational literature on altering the home environment to minimize exposure to allergens or irritants. This approach is thorough and cost effective. By providing education for patients and their families, CHOC Specialists Allergy, Asthma and Immunology physicians promote better understanding and management of the condition through the proper use of medications, environmental controls and other preventive measures to alleviate symptoms and minimize reactions.
Active Participants in the Latest Clinical Research CHOC Specialists Allergy
Asthma & Immunology physicians serve as principal investigators for many clinical research studies, providing patients with access to the newest treatment options available. Recent studies have included new medications for asthma, allergic rhinitis, sinusitis and eczema.
Recognized within the community for excellence, CHOC Specialists Allergy, Asthma and Immunology physicians are board certified pediatric subspecialists, who have been practicing in Orange County for over 35 years. They provide medical directorship for the Allergy, Asthma and Immunology program at CHOC. As a community service, they report on daily mold and pollen counts to the Orange County Register.
CHOC Specialists Allergy, Asthma and Immunology physicians direct a summer camp for asthmatic children sponsored by the American Lung Association and participate in community education lectures and seminars.
Additionally, CHOC Children’s Allergy and Immunology Specialists are proud to be partner with the CHOC Children’s Gastroenterology Specialists to offer one of the only Eosinophilic Esophagitis Clinics in Southern California. The multidisciplinary team of allergists, gastroenterologists and dietitians, work with children from infancy to age 18 to help diagnose and treat eosinophilic esophagitis (EoE) using the very latest research-based treatments.
When a child is first diagnosed with EoE, it is an overwhelming experience. The clinic team provides the expertise and support needed to manage the patient’s health and wellbeing. The clinic meets every first and third Wednesday of the month. During the initial stages of care, patients may need to attend clinic every one to three months depending on the severity of the child’s symptoms. The EoE team also provides support services outside of the clinic through e-mail and phone calls. Once there is resolution of the EoE and the trigger is identified, we recommend yearly visits for follow-up.
The CHOC Specialists Cardiology Division strives to provide the best possible care for infants, children and adolescents with acquired or congenital heart disease as well as adults with congenital heart disease. Comprehensive inpatient and outpatient services are offered including collaborative care with the intensive care team in the dedicated Cardiovascular Intensive Care Unit (CVICU). We have a strong educational program for patients and families and we offer complete cardiovascular care.
Leading-Edge Diagnostic Capabilities & Treatment
CHOC Specialists Cardiology physicians provide the following services:
Recognized For Excellence
CHOC Specialists Cardiology physicians serve as the Medical Directors for the pediatric cardiology services provided at CHOC. Our cardiologists work closely with the pediatric cardiac surgeons at CHOC. Collaboration with pediatric intensivists in the hospital’s dedicated CVICU as well as Pediatric Intensive Care Unit (PICU) and Neonatal Intensive Care Unit (NICU) provides a comprehensive, multidisicplinary approach to patient care.
Active Participants in the Latest Clinical Research
CHOC Specialists Cardiology has an active research program and has representation at the pediatric study section at the National Institute of Health (NIH). Ongoing projects include evaluating new treatments for respiratory syncytial virus (RSV) in children with cardiac disease and newer noninvasive methodologies in monitoring children after cardiac surgery. The Division has assisted in the development of new catheters to evaluate coronary problems in children. They recently participated in a national study to evaluate newer inotropic agents following heart surgery as well as management strategies for hypoplastic left heart syndrome. Future proposed projects involve an important collaboration between the CHOC Specialists Cardiology Division and the University of California, Irvine.
“The premier pediatric cardiology practice in Orange County, CA.”
The CHOC Specialists Cardiology Physicians are distinguished by their commitment to clinical excellence and research and through their training and faculty appointments at many of the nation’s most prestigious schools and hospitals including the University of California, Los Angeles (UCLA), Children’s Hospital of Los Angeles (CHLA), Boston Children’s Hospital, Philadelphia Children’s Hospital, and Texas Children’s Hospital in Houston, TX.
Anthony Chang, M.D. is the CHOC Specialists Division Chief of Cardiology, Medical Director of the CHOC Children’s Heart Institute, and an Associate Clinical Professor at University of California, Irvine School of Medicine.
Dr. Chang completed his pediatric residency and pediatric cardiology fellowship training at Children’s Hospital National Medical Center, in Washington D.C., and Children’s Hospital of Philadelphia, respectively. He graduated from the Georgetown University Medical School, in Washington, D.C., and received his undergraduate degree from Johns Hopkins University, in Baltimore. Dr. Chang has a master’s degree in business administration from the University of Miami School of Business and a master’s degree in public health from the University of California, Los Angeles (UCLA).
Dr. Chang has held faculty appointments at the Harvard University School of Medicine, the University of Southern California School of Medicine and the University of Pennsylvania Medical School, in Philadelphia. He also directed the cardiac intensive care programs at Children’s Hospital of Los Angeles and Miami Children’s Hospital.
Prior to joining CHOC, Dr. Chang was medical director of the pediatric cardiac intensive care service and chief of critical care cardiology at Texas Children’s Hospital, and a tenured associate professor in pediatrics at the Baylor College of Medicine. Dr. Chang is widely published and on the editorial board of several publications. He frequently publishes articles, presents lectures on a variety of topics and has published books, including Pediatric Cardiac Intensive Care and Heart Failure in Children. He has served as program director for several large international conferences and symposia.
1980 “Academic Honors” (Johns Hopkins University Premedical Program, Baltimore, MD.)
1988 “Best Resident Award” (Academic Forum, Children’s Hospital National Medical Center, Washington, DC.)
1993 “Best Research Award in Critical Care Medicine” (American Academy of Pediatrics, San Francisco, CA.)
1995 “Best Teaching Award” (Division of Critical Care Medicine, Children’s Hospital of Los Angeles, CA.)
1998 “McGaw Award for Academic Excellence” (graduated first in class – Health Administration Executive Program, Miami, FL.)
2000 “Special Teaching Award” (Department of Pediatrics, Miami Children’s Hospital, Florida)
2003 “Presidential Citation Award” (Society of Critical Care Medicine)
2007 – 2008 “Best Doctors in America” (Best Doctors)
2008 “Outstanding Teaching Award” (UCLA Pediatric Cardiology Program)
2008 “Dean’s Outstanding Scholarship Award” (graduated first in class) and “Delta Omega” (Public Health Honor Society)
2009 “America’s Top Cardiologist” (Consumer’s Research Council of America)
2010 “California’s Top Doctors” (Orange Coast Magazine)
2011 – 2012 “Best Doctors in America” (Best Doctors)
2012 “Physician of Excellence” (Orange County Medical Association) (OCMA)
1. Use of Novel Agents in the Treatment of Pulmonary Hypertension
2. Artificial Intelligence in Decision-making in Pediatric Cardiology
3. Heart Failure in Children: Current Therapy and Management
Publications† link:
Dr. Anthony Chang Publications
( † Disclaimer: This search is powered by Google Scholar. Google Scholar is a third-party website with no affiliation with CHOC.)
[youtubegallery]
CHOC physicians, patients and their families talk about how CHOC provides expert pediatric care|http://www.youtube.com/watch?v=FYhgKwYHaHY&NR=1
Dr. Anthony Chang, Medical Director of the CHOC Childrens Heart Institute discusses Life-threatening Events Associated with Pediatric Patients in Sports (LEAPS)|http://www.youtube.com/watch?v=lCAiVJomg60&feature=player_embedded
“The Call” CHOC Documentary featuring Dr. Chang|http://www.youtube.com/watch?v=41v3q-aeqgc
[/youtubegallery]
CHOC Specialists Cardiology practice office moving – Monday, August 1st, 2011
Dr. Anthony Chang & Dr. Anjan Batra Honored by the Orange County Board of Education for LEAPS
CHOC PEDIATRIC SUBSPECIALTY FACULTY, INC., PLEDGES $1 MILLION
TO “CHANGE CHOC, CHANGE THE WORLD” CAMPAIGN
(Orange, Calif., May 21, 2010) –CHOC Specialists, a medical pediatric specialty physician group serving CHOC Children’s, is dedicated to ensuring children’s healthcare needs are met for generations to come. As part of this commitment, the physicians of the PSF have pledged $1 million to the “Change CHOC, Change the World” campaign.
The comprehensive campaign will help CHOC to become a sustainable world-class pediatric institution by building a state-of-the-art facility; building a substantial endowment to support recruiting more of the world’s top pediatric experts, and fostering an environment of innovation and discovery; and building upon the academic and research affiliation with UC Irvine and its School of Medicine. The CHOC Children’s Foundation is committed to raising $125 million for the campaign by July 2013. PSF’s generous contribution will name the outdoor play area in the new tower.
“PSF is excited to support this campaign, transforming the delivery of pediatric healthcare in Orange County. Our children and families deserve a world-class, pediatric-focused healthcare system and we will remain a fierce advocate on their behalf,” said Paul Lubinsky, M.D., PSF chair and associate director of the CHOC Children’s Hospital Pediatric Intensive Care Unit.
The seven-story tower, set to open on CHOC’s Orange campus in Spring 2013, will feature leading design and safety principles, a family-centered care environment, and increased capacity to meet the region’s future healthcare needs. The tower will also include new and advanced pediatric emergency department, operating rooms and related services, laboratory, pathology, imaging and radiology services.
To learn more about the “Change CHOC, Change the World” campaign, please go to http://www.iamforchildren.com
As a neonatologist, Dr. Sudeep Kukreja works 80-100 hours a week tending to some of the littlest and sickest of patients. While many people may see these infants as weak, Dr. Kukreja draws strength from them, and was inspired to run 26.2 miles in their honor. Despite having little time to train and an injured knee, Dr. Kukreja recently finished the Los Angeles Marathon – his first. Not only did he cross the finish line under six hours, he also brought in close to $7,000 for the NICU, thanks to the friends and colleagues who sponsored him. Completing the race was a victory for Dr. Kukreja and a wonderful celebration of the victories he helps secure for CHOC’s NICU babies
Grow Up Great: A Community Partner Update
February 28, 2010
From Children and Families Commission of Orange County
Grow Up Great: A Community Partner Update – Director’s Message
For 10 years, the Children & Families Commission of Orange County has used Proposition 10 tobacco tax revenue to help our youngest members of society get a solid start in life. But providing funds is just one part of the story. Helping Orange County’s children to be healthy and to thrive requires compassionate, talented, selfless individuals-dedicated to serving children and their families. These people are agents of change. And this month the Commission is launching a campaign to honor them.
The campaign’s singular focus is people, the heart of everything the Commission and our partners have accomplished over the past decade. So from February through November 2010, we will highlight 10 individuals who serve so tirelessly on behalf of Orange County’s children. We hope that by recognizing these few, the campaign will raise awareness of the many individuals and programs that are helping our children to Grow Up Great.
To kick off the campaign, Agents of Change – 10 People Making a Difference in the Lives of Young Children, we honor Dr. Joseph Donnelly and the program he leads. For OC Kids Neurodevelopmental Center, a program that helps children who have developmental disorders.
Dr. Joe Donnelly was recruited from Baystate Medical Center Children’s Hospital in Springfield, Massachusetts to UC Irvine in 2002, and now heads the Neurodevelopmental Center in Orange County. What makes him so uniquely qualified-aside from the specialty degrees in Pediatrics and Neurology and extensive experience-is his commitment to the earliest identification, treatment, and support for children with developmental, behavioral or learning disorders like autism and ADHD. For OC Kids is the only center of its kind in Orange County, providing comprehensive services for children birth through age five years.
Using a team approach, For OC Kids gives these children the range of support they need in one place-including Pediatric Neurology, Developmental-Behavioral Pediatrics, a Pediatric Nurse Practitioner, and a Social Worker. Family-centered care is the focus of the For OC Kids team. Through the Family Support and Education Program, families receive training, individual consultations, and connection to community resources.
From the outset, the Commission supported For OC Kids Neurodevelopmental Center, bringing the partners of CHOC and UC Irvine together, and funding this important program that fills such a critical need.
On behalf of the Commission and all the children and families whose lives are touched, I congratulate Dr. Donnelly, and For OC Kids, and all of Orange County’s Agents of Change!
Michael Ruane
Executive Director
February 24, 2010
CHOC Children’s Hematology Advanced Diagnostics Laboratory was awarded accreditation by the Accreditation Committee of the College of American Pathologists (CAP), based on the results of a recent successful onsite inspection. The national recognition highlights the excellent services provided through the lab.
“We are very proud to receive this coveted recognition for our lab, which is intended to provide much needed diagnostic services to patients with rare disorders. These studies are not offered in routine laboratories, and now patients with blood problems can be diagnosed sooner and monitored more closely,” said Dr. Diane Nugent, Director of Hematology and the Advanced Diagnostic Laboratory at CHOC Children’s. “Since we are a referral center for inherited blood disorders, it has always been our goal to bring these special tests to our community here in Orange County and throughout the state.”
The CAP Laboratory Accreditation Program began in the 1960s and is recognized by the federal government as being equal to or more stringent than the government’s own inspection program. During the CAP accreditation process, inspectors examine the laboratory’s records and quality control of procedures for the preceeding two years. In addition, CAP inspectors examine staff qualifications, laboratory equipment and facilities, safety program and record, and overall laboratory management. The inspection program is designed to ensure the highest standard of care for all laboratory patients.
The CHOC Hematology Advanced Diagnostics Laboratory is an integral part of the care provided patients that includes comprehensive, multidisciplinary evaluation and treatment for pediatric hematologic diseases.
December 03, 2009
CHOC Children’s Hospital is one of 45 hospitals – and one of only eight children’s hospitals across the nation- named to the “Leapfrog 2009 Top Hospitals” list, based on results from The Leapfrog Hospital Survey. CHOC’s survey score was 97.2 points out of 100 possible points, as compared to an average score of 72.4 for children’s hospitals across the country. The survey (found at www.leapfroggroup.org) is the only national, public comparison of hospitals on key issues including mortality rates for certain common procedures, infection rates, safety practices and measures of efficiency.
According to The Leapfrog Group CEO Leah Binder, “This year’s class of Top Hospitals not only hits the mark in areas such as medication error prevention and ICU deaths, but they also use their resources wisely, providing excellent and efficient outcomes for patients. Regardless of what happens to healthcare reform, these hospitals are the future.”
Survey criteria included: meeting Leapfrog standards for implementing computerized physician order entry systems that have been shown to reduce medication errors by up to 85 percent; meeting stringent performance standards for complex, high-risk procedures; meeting standards for staffing the intensive care unit, shown to reduce mortality by 40 percent or more; and scoring in the top decile in the nation for efficiency – scored by the Leapfrog Hospital Recognition Program incorporating quality outcomes, length of stay, readmission rates, and incidence of hospital-acquired conditions and infections.
Pointing to a study by Dr. Ashish Jha at Harvard Medical School published in 2008 in the Journal of the Joint Commission, Binder says, “We know from research that Leapfrog-reporting hospitals are among the best in the country, and they demonstrate through Leapfrog that they set ambitious goals for their performance.” (Dr. Jha’s study concluded that Leapfrog hospitals have lower mortality and better quality of care than those that don’t report to Leapfrog.)
About The Leapfrog Group: Founded in 2000 by the Business Roundtable, The Leapfrog Group uses the collective leverage of large purchasers of healthcare to initiate breakthrough improvements in the safety, quality and affordability of health care for Americans. The Leapfrog Hospital Survey is the gold standard for comparing hospitals’ performance on the national standards of safety, quality and efficiency. Hospitals that participate in the survey achieve hospital-wide improvements that translate into millions of lives and dollars saved.
CHOC Children’s is exclusively committed to the health and well-being of children through clinical expertise, advocacy, outreach and research that brings advanced treatment to pediatric patients. Affiliated with the University of California, Irvine, CHOC’s regional healthcare network includes two state-of-the-art hospitals in Orange and Mission Viejo, several primary and specialty care clinics, a pediatric residency program, and four centers of excellence – The CHOC Children’s Heart, Cancer, Neuroscience, and Orthopaedic Institutes.
CHOC is one of only eight children’s hospitals in the nation named a “2009 Leapfrog Top Hospital.” CHOC earned the Silver Level CAPE Award from the California Council of Excellence, the only children’s hospital in California to ever earn this distinction, and was awarded Magnet designation, the highest honor bestowed to hospitals for nursing excellence. Recognized for extraordinary commitment to high-quality critical care standards, CHOC is the first children’s hospital in the United States to earn the Beacon Award for Critical Care Excellence.